| Descriptor English: | 20-alpha-Dihydroprogesterone | ||||||
| Descriptor Spanish: |
20-alfa-Dihidroprogesterona
| ||||||
| Descriptor Portuguese: | 20-alfa-Di-Hidroprogesterona | ||||||
| Descriptor French: | 20alpha-Dihydroprogestérone | ||||||
| Entry term(s): |
20 alpha Dihydroprogesterone 20 alpha Hydroxy 4 Pregnen 3 One 20 alpha Hydroxyprogesterone 20 alpha-Dihydroprogesterone 20 alpha-Hydroxy-4-Pregnen-3-One 20 alpha-Hydroxyprogesterone 20-alpha-Hydroxyprogesterone 20-alpha-hydroxy- Pregn-4-en-3-one 20alpha Hydroxypregn 4 Ene 3 One 20alpha-Hydroxypregn-4-Ene-3-One Dihydroprogesterone Pregn 4 en 3 one, 20 alpha hydroxy Pregn-4-en-3-one, 20-alpha-hydroxy- |
||||||
| Tree number(s): |
D04.210.500.745.745.654.829.100 D06.472.334.851.687.750.074 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004092 | ||||||
| Scope note: | A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Progestins |
||||||
| Registry Number: | 145-14-2 | ||||||
| CAS Type 1 Name: | Pregn-4-en-3-one, 20-hydroxy-, (20S)- | ||||||
| Previous Indexing: |
Progesterone (1974) |
||||||
| Public MeSH Note: | 2004; see DIHYDROPROGESTERONE 1991-2003, see PROGESTERONE 1975-1990 |
||||||
| History Note: | 2004 (1975) |
||||||
| DeCS ID: | 4132 | ||||||
| Unique ID: | D004092 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1974/11/11 | ||||||
| Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
|
20-alpha-Dihydroprogesterone
- Preferred
| Concept UI |
M0006411 |
| Scope note | A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA. |
| Preferred term | 20-alpha-Dihydroprogesterone |
| Entry term(s) |
20 alpha Dihydroprogesterone 20 alpha Hydroxy 4 Pregnen 3 One 20 alpha Hydroxyprogesterone 20 alpha-Dihydroprogesterone 20 alpha-Hydroxy-4-Pregnen-3-One 20 alpha-Hydroxyprogesterone 20-alpha-Hydroxyprogesterone 20-alpha-hydroxy- Pregn-4-en-3-one 20alpha Hydroxypregn 4 Ene 3 One 20alpha-Hydroxypregn-4-Ene-3-One Dihydroprogesterone Pregn 4 en 3 one, 20 alpha hydroxy Pregn-4-en-3-one, 20-alpha-hydroxy- |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
